Zdrowie i gospodarka · 08/09/2016
FDA Renewal of Oncologic Drugs Advisory Committee
The FDA is renewing the Oncologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on September 1, 2018.
Zdrowie i gospodarka · 08/09/2016
The FDA is renewing the Oncologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on September 1, 2018.